News
Exciva has raised US$59.4m in series B funding to support a phase 2 trial of its Alzheimer's therapy. The clinical-stage biopharmaceutical company is developing treatments for behavioural symptoms associated with the condition. Neuropsychiatric symptoms such as agitation and other behavioural symptoms affect up to 90 per cent of patients with severe Alzheimer's disease, driving caregiver [...]
SciNeuro Pharmaceuticals has entered a worldwide licensing and collaboration agreement with Novartis to advance its amyloid beta-targeted antibody programme for Alzheimer's disease. The programme has identified de novo antibody candidates that incorporate what SciNeuro describes as its proprietary blood-brain barrier shuttle technology, designed to help drugs cross the protective barrier around the brain, and which [...]
L-Nutra has raised US$36.5m in series D funding for what it describes as science-driven nutrition for longevity and nutrition as medicine. The round brings its series D total to US$83.5m, the company said. As part of the investment, Mubadala and L-Nutra will establish a local joint venture in Abu Dhabi to produce scientific medical nutrition [...]
Shingles vaccination may slow biological ageing in older adults, research suggests. The study examined more than 3,800 people aged 70 and older and found that those who received the vaccine showed slower biological ageing on average than unvaccinated individuals. The study used data from a nationally representative US survey to assess how shingles vaccination related [...]
Thousands of men in England will get the prostate cancer drug abiraterone on the NHS within weeks. For the first time, patients in England whose cancer has not spread will be able to receive abiraterone as the health service widens access to the treatment. Around 2,000 men diagnosed in the last three months whose cancer [...]
Sharp rises in blood sugar after meals may raise Alzheimer’s risk, according to genetic analysis of more than 350,000 adults. The findings point to after-meal glucose, rather than overall blood sugar, as a possible factor in long-term brain health. Researchers examined genetic and health data from over 350,000 UK Biobank participants aged 40 to 69, [...]
While a healthy lifestyle with regular exercise can improve longevity, the key to ageing well is determined by the brain, says a new paper. Published earlier this month and entitled: ’The Brain Is the Rate-Limiting Organ of Longevity’ it contends that ‘Longevity is not limited by how long the body survives, but by how long [...]
Biological age testing pioneer GlycanAge plans to use the cash raised from its recent US$8.7m funding round to expand its reach, explore additional bio-marking capabilities of its unique technology and fund its recently-opened Californian lab. Agetech World editor Peter McCusker met Jonathan White, head of its UK office, to find out more. GlycanAge was founded [...]
Non-invasive sound stimulation altered Alzheimer’s-linked proteins in aged monkeys in a recent study, with effects lasting more than five weeks. Alzheimer’s involves abnormal amyloid proteins that form plaques and damage synapses, the junctions between nerve cells. Cerebrospinal fluid is the liquid that bathes the brain and spinal cord. In a study of nine rhesus macaques [...]
Veteran male athletes may face higher heart risk during exercise if they have existing heart scarring, new research suggests. The study found that male endurance athletes aged over 50 were more likely to experience abnormal heart rhythms during training if scarring was present. Nine in 10 sudden cardiac deaths during sport occur in older male [...]
